ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis
Thomas Worzfeld1, Jakub M Swiercz, Mario Looso
1Max-Planck-Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany.
Abstract:
Diagnosis of metastatic breast cancer is associated with a very poor prognosis. New therapeutic targets are urgently needed, but their development is hampered by a lack of understanding of the mechanisms leading to tumor metastasis. Exemplifying this is the fact that the approximately 30% of all breast cancers overexpressing the receptor tyrosine kinase ErbB-2 are characterized by high metastatic potential and poor prognosis, but the signaling events downstream of ErbB-2 that drive cancer cell invasion and metastasis remain incompletely understood. Here we show that overexpression of ErbB-2 in human breast cancer cell lines leads to phosphorylation and activation of the semaphorin receptor Plexin-B1. This was required for ErbB-2-dependent activation of the pro-metastatic small GTPases RhoA and RhoC and promoted invasive behavior of human breast cancer cells. In a mouse model of ErbB-2-overexpressing breast cancer, ablation of the gene encoding Plexin-B1 strongly reduced the occurrence of metastases. Moreover, in human patients with ErbB-2-overexpressing breast cancer, low levels of Plexin-B1 expression correlated with good prognosis. Our data suggest that Plexin-B1 represents a new candidate therapeutic target for treating patients with ErbB-2-positive breast cancer.
Insights
Plexin-B1 activation drives metastasis in ErbB-2 positive breast cancer. Targeting Plexin-B1 may improve outcomes for patients with this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Metastatic breast cancer has a poor prognosis, necessitating new therapeutic targets.
- Understanding metastasis mechanisms is crucial for developing effective treatments.
- ErbB-2 overexpression in breast cancer correlates with high metastatic potential and poor prognosis, yet downstream signaling is not fully understood.
Purpose of the Study:
- To investigate the role of Plexin-B1 in ErbB-2-driven breast cancer metastasis.
- To identify downstream signaling pathways mediating ErbB-2's pro-metastatic effects.
Main Methods:
- Utilized human breast cancer cell lines overexpressing ErbB-2.
- Examined Plexin-B1 phosphorylation and activation.
- Assessed the impact of Plexin-B1 on small GTPase activation (RhoA, RhoC) and cell invasion.
- Employed a mouse model of ErbB-2-overexpressing breast cancer with Plexin-B1 gene ablation.
- Correlated Plexin-B1 expression levels with patient prognosis in ErbB-2 positive breast cancer.
Main Results:
- ErbB-2 overexpression induced Plexin-B1 phosphorylation and activation.
- Plexin-B1 activation was essential for ErbB-2-mediated RhoA and RhoC activation.
- Plexin-B1 promoted invasive behavior in human breast cancer cells.
- Ablation of Plexin-B1 significantly reduced metastasis in a mouse model.
- Low Plexin-B1 expression in patients correlated with a favorable prognosis.
Conclusions:
- Plexin-B1 is a key mediator of ErbB-2-driven breast cancer cell invasion and metastasis.
- Plexin-B1 represents a potential therapeutic target for ErbB-2-positive breast cancer.
Related Concept Videos
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal


